Additionally, we analyzed the DDR2, SHP2 and SRC activity levels in the tumor lysates using Western blotting (Figure 5d), observing a significant decrease in protein levels for the dual inhibitor group relative to the untreated group. The gene discussed is PTPN11; the disease is neoplasm.